Henry VanBrocklin, PhD

Dr. Henry VanBrocklin is Professor and Director of Radiopharmaceutical Research in the Department of Radiology and Biomedical Imaging at the University of California San Francisco (UCSF). His work spans many radiopharmaceutical science disciplines from short-lived radioisotope production to the development of new strategies for labeling biomolecules with imaging and therapeutic isotopes. His current research interests include design of imaging agents targeting cancer cell surface markers, preparation of probes for neurodegenerative disorders including AD and ALS, application of imaging in drug development and elaboration of zirconium-89 labeled antibodies for imaging rheumatoid arthritis, HIV reservoirs and Long COVID. He has translated >10 radiopharmaceuticals for evaluation in human studies. He was selected as a Distinguished Investigator by the Academy for Radiology & Biomedical Imaging Research in 2018, the recipient of the 2020 Michael J. Welch Award from the Radiopharmaceutical Science Council of the SNMMI, and the 2023 Paul Aebersold Award from the SNMMI.

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none